Skip to main content

Star Scientific


, which makes products that aim to prevent the formation of carcinogens in tobacco leaf and smoke, soared more than 50% on no news Friday afternoon. More recently, the stock was up 42.8% to $1.97 on volume more than seven times its three-month average.

Reddy Ice Holdings

( FRZ) plummeted as much as 48% after it said in a press release that it the Department of Justice executed a search warrant at its Dallas office in connection with a probe into the packaged ice industry. Shares more recently were trading down 37% to $14.55.

Also falling,


(ALKS) - Get Alkermes Plc Report

edged down 9.2% to $11.26 after the company said it expects

Eli Lilly

(LLY) - Get Eli Lilly and Company Report

Scroll to Continue

TheStreet Recommends

to discontinue its program for AIR Insulin, an inhaled insulin product that the companies are developing for diabetes.

Alkermes said in a press release that it's not aware of any safety, efficacy or manufacturing issues, and believes the decision will be based on Lilly's evaluation of its own business prospects.

Alkermes is a component of the Nasdaq biotechnology index, which was down 0.4% at 751.81.

Elsewhere, a day after shares dropped more than 40%,

Omrix Biopharmaceuticals

( OMRI) took a breath. Shares recovered $1.51, or 10.7%, landing at $15.60. Post earnings, Rodman & Renshaw analyst Michael King placed the stock under review, while Citi analyst Matthew Dodds stuck with a buy rating, but lowered his price target to $23 from $33. Also Cowen & Co. analyst Eli Kammerman reiterated an outperform rating.

Gun maker

Smith & Wesson


jumped 12.2% after fiscal third-quarter earnings beat Wall Street's estimates. The company swung to a loss of $1.8 million, or 4 cents per share, compared with a profit of $1.6 million, or 4 cents per share, in the year-ago period. Analysts polled by Thomson Financial expected a loss of 6 cents a share, excluding items. The stock gained 52 cents to $12.80.

This article was written by a staff member of